
X4 PHARMACEUTICALS INC
XFORNASDAQ๐ #2937 by market capEarnings Nov 4US Equity
$4.48โฒ $0.20 (+4.56%)
Live1hโฒ 1.0%
24hโฒ 4.6%
7dโฒ 8.0%
14dโฒ 11.9%
30dโฒ 10.4%
1yโฒ 73.4%
๐ฆMarket Cap
$422M
Small Cap
๐Revenue Growth (YoY)
-71.3%
Declining
๐Gross Margin
81.8%
High
๐ตFCF Margin
โ
โ๏ธP/S Ratio
48.6x
Expensive
Otter Score
66
Fair
Earnings
Q3 ยท 2026Reported 2026-08-07Earnings Per Share
Actual
-0.13
Expected
-0.18
beat
+26.10%
YoY +96.30%
Revenue
Actual
$8.81M
Expected
$2.42M
beat
+263.90%
YoY +346.30%
Consensus estimates
Recent quarters
Q3 2026
-0.13
beat
Q2 2026
-0.16
beat
Q1 2026
-0.22
beat
Q4 2025
-0.69
beat